The Six-Patient Study Underneath an Interim Readout

A 40-patient Phase 2 trial of the topical gel TolaSure for epidermolysis bullosa simplex is nearing an interim data check, but the predecessor study its confidence rests on enrolled six adults instead of the ten planned and still has no results posted on ClinicalTrials.gov more than three years after it ended.